Proteostasis Therapeutics, Inc. Presents Data at 11th International Conference on Alzheimer’s and Parkinson’s Diseases
3/8/2013 8:41:01 AM
More...
|
Proteostasis Therapeutics, Inc. Presents Data at Two Scientific Conferences for Lead Programs in Cystic Fibrosis and Parkinson's Disease
10/18/2012 9:48:08 AM
More...
|
Proteostasis Therapeutics, Inc. Presents Data at Multiple Scientific Conferences Highlighting Novel Approach to Neurodegenerative Diseases and Cystic Fibrosis
8/14/2012 9:41:14 AM
More...
|
Proteostasis Therapeutics, Inc. Announces Expansion of Collaboration With The Scripps Research Institute to Broaden Cystic Fibrosis Program
7/26/2012 10:10:35 AM
More...
|
Proteostasis Therapeutics, Inc. Announces Collaboration With Cystic Fibrosis Foundation Therapeutics, Inc.
5/7/2012 9:50:13 AM
More...
|
Proteostasis Therapeutics, Inc. Announces Appointment of Mark J. Enyedy as Chief Executive Officer
10/20/2011 8:08:55 AM
More...
|
Harvard University’s Alfred Goldberg, Ph.D., Daniel Finley, Ph.D., and Randall King, M.D., Ph.D., Named Harvard University Scientific Co-Founders
5/5/2011 8:40:10 AM
More...
|
Proteostasis Therapeutics, Inc. Licenses Novel Protein Clearance Targets, Compounds from Harvard University
4/26/2011 9:10:51 AM
More...
|
Proteostasis Therapeutics, Inc. Announces Additions of Key Executives; Peter H. Reinhart Joins as CSO and Gregory P. Licholai is Appointed COO
3/25/2010 10:49:54 AM
More...
|
Proteostasis Therapeutics, Inc., a Rich Boston Biotech with San Diego Ties, Grows to Pursue Diseases of Aging
2/18/2010 8:01:13 AM
More...
|
|